Millipore Sigma Vibrant Logo

407256 IGF-II, CF, Mouse, Recombinant

IGF-II, CF, Mouse, Recombinant: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: Multiplication-stimulating polypeptide Somatomedin A

View Products on Sigmaaldrich.com
407256
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

Purity
≥97% by SDS-PAGE

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
407256-50UG
Verifica della disponibilità in corso...
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 Bottiglia di vetro 50 μg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      OverviewRecombinant, mouse insulin-like growth factor II (IGF-II) consisting of amino acids 25-91 and expressed in E. coli. Mouse IGF-II is synthesized as a 180 amino acid preproprecursor. Mature IGF-II is 91% and 97% amino acid identical to human and rat IGF-II, respectively.
      Catalogue Number407256
      Brand Family Calbiochem®
      SynonymsMultiplication-stimulating polypeptide Somatomedin A
      References
      ReferencesOstrovsky, O., et al. 2009. Mol. Biol. Cell 20, 1855.
      Chao, W. & P. A. DAmore, 2008. Cytokine Growth Factor Rev. 19, 111.
      Belfiore, A., 2007. Curr. Pharm. Des. 13, 671.
      Cornish, J., et al. 2007. Am. J. Physiol. Endocrinol. Metab. 292,E117.
      Merrick, D., et al. 2007. BMC Dev. Biol. 7, 65.
      Pavelic, J., et al. 2007. Indian J. Med. Res. 125, 511.
      VarelaNieto, I., et al. 2007. Curr. Pharm. Des. 13,687.
      Denley, A. et al. 2005. Cytokine Growth Factor Re,v. 16, 421.
      LeRoith, D. & C.T. Roberts Jr., 2003. Cancer Lett. 195,127.
      Buchanan, C.M., et al. 2001. Biochem. J. 360, 431.
      Werner, H. & D. LeRoith, 2000. Cell. Mol. Life Sci. 57, 932.
      Goya, L., et al. 1999. J. Biol. Chem. 274 24633.
      Daughaday, W.H., et al. 1993. Proc. Natl. Acad. Sci. USA 90, 5823.
      Holthuizen, P.E., et al. 1993. Regul. Pept. 48, 77.
      McCarthy, T.L., et al. 1992. Endocrinology 130, 1303.
      Zindy, F., et al. 1992. J. Hepatol. 14, 30.
      Rotwein, P. & L.J. Hall, 1990. DNA Cell Biol. 10,725.
      Rotwein, P., et al. 1988. Proc. Natl. Acad. Sci. USA 85, 265.
      Stempien, M.M., et al. 1986. DNA 5, 357.
      Product Information
      FormSolid
      FormulationLyophilized from 0.2 µm sterile-filtered Acetonitrile, TFA.
      Quality LevelMQ100
      Applications
      Biological Information
      Biological activityED₅₀ = 2-10 ng/ml as measured in a serum-free cell proliferation assay using MCF-7 human breast adenocarcinoma cells.
      Purity≥97% by SDS-PAGE
      Physicochemical Information
      ContaminantsEndotoxin: <1.0 EU/µg protein
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      407256-50UG 04055977188745

      Documentation

      IGF-II, CF, Mouse, Recombinant MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      IGF-II, CF, Mouse, Recombinant Certificati d'Analisi

      TitoloNumero di lotto
      407256

      Riferimenti bibliografici

      Panoramica delle referenze
      Ostrovsky, O., et al. 2009. Mol. Biol. Cell 20, 1855.
      Chao, W. & P. A. DAmore, 2008. Cytokine Growth Factor Rev. 19, 111.
      Belfiore, A., 2007. Curr. Pharm. Des. 13, 671.
      Cornish, J., et al. 2007. Am. J. Physiol. Endocrinol. Metab. 292,E117.
      Merrick, D., et al. 2007. BMC Dev. Biol. 7, 65.
      Pavelic, J., et al. 2007. Indian J. Med. Res. 125, 511.
      VarelaNieto, I., et al. 2007. Curr. Pharm. Des. 13,687.
      Denley, A. et al. 2005. Cytokine Growth Factor Re,v. 16, 421.
      LeRoith, D. & C.T. Roberts Jr., 2003. Cancer Lett. 195,127.
      Buchanan, C.M., et al. 2001. Biochem. J. 360, 431.
      Werner, H. & D. LeRoith, 2000. Cell. Mol. Life Sci. 57, 932.
      Goya, L., et al. 1999. J. Biol. Chem. 274 24633.
      Daughaday, W.H., et al. 1993. Proc. Natl. Acad. Sci. USA 90, 5823.
      Holthuizen, P.E., et al. 1993. Regul. Pept. 48, 77.
      McCarthy, T.L., et al. 1992. Endocrinology 130, 1303.
      Zindy, F., et al. 1992. J. Hepatol. 14, 30.
      Rotwein, P. & L.J. Hall, 1990. DNA Cell Biol. 10,725.
      Rotwein, P., et al. 1988. Proc. Natl. Acad. Sci. USA 85, 265.
      Stempien, M.M., et al. 1986. DNA 5, 357.
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision21-Sepmtember-2011 RFH
      SynonymsMultiplication-stimulating polypeptide Somatomedin A
      DescriptionRecombinant, mouse insulin-like growth factor II (IGF-II) consisting of amino acids 25-91 and expressed in E. coli. Mouse IGF-II is synthesized as a 180 amino acid preproprecursor. Mature IGF-II is 91% and 97% amino acid identical to human and rat IGF-II, respectively.
      FormSolid
      FormulationLyophilized from 0.2 µm sterile-filtered Acetonitrile, TFA.
      Purity≥97% by SDS-PAGE
      ContaminantsEndotoxin: <1.0 EU/µg protein
      Biological activityED₅₀ = 2-10 ng/ml as measured in a serum-free cell proliferation assay using MCF-7 human breast adenocarcinoma cells.
      SolubilityReconstitute to 100 µg/ml in sterile PBS.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesOstrovsky, O., et al. 2009. Mol. Biol. Cell 20, 1855.
      Chao, W. & P. A. DAmore, 2008. Cytokine Growth Factor Rev. 19, 111.
      Belfiore, A., 2007. Curr. Pharm. Des. 13, 671.
      Cornish, J., et al. 2007. Am. J. Physiol. Endocrinol. Metab. 292,E117.
      Merrick, D., et al. 2007. BMC Dev. Biol. 7, 65.
      Pavelic, J., et al. 2007. Indian J. Med. Res. 125, 511.
      VarelaNieto, I., et al. 2007. Curr. Pharm. Des. 13,687.
      Denley, A. et al. 2005. Cytokine Growth Factor Re,v. 16, 421.
      LeRoith, D. & C.T. Roberts Jr., 2003. Cancer Lett. 195,127.
      Buchanan, C.M., et al. 2001. Biochem. J. 360, 431.
      Werner, H. & D. LeRoith, 2000. Cell. Mol. Life Sci. 57, 932.
      Goya, L., et al. 1999. J. Biol. Chem. 274 24633.
      Daughaday, W.H., et al. 1993. Proc. Natl. Acad. Sci. USA 90, 5823.
      Holthuizen, P.E., et al. 1993. Regul. Pept. 48, 77.
      McCarthy, T.L., et al. 1992. Endocrinology 130, 1303.
      Zindy, F., et al. 1992. J. Hepatol. 14, 30.
      Rotwein, P. & L.J. Hall, 1990. DNA Cell Biol. 10,725.
      Rotwein, P., et al. 1988. Proc. Natl. Acad. Sci. USA 85, 265.
      Stempien, M.M., et al. 1986. DNA 5, 357.